We are a venture capital firm focused on medtech and medical device companies

Engage combines the knowledge, focus, and operating experience of a sector-specialized venture capital team with deal-by-deal investor participation flexibility

Our investment thesis

One sector. Every stage. Our own money in every deal.

We are veteran early-stage investors, entrepreneurs, and operators. We personally curate and invest in every company that we present to our Investor Network.

Sector

Medtech only

Medical device, combination products, and digital health. We do not invest in biotech or pharma.

Stage

Pre-Seed through late-stage

We come in early, and keep backing companies through follow-on rounds.

Diligence

Operator-led

Our partners have founded, built, run, and exited medtech companies. Due diligence is done by people who have carried the regulatory, clinical, and commercial risk themselves.

Alignment

We personally invest in every deal

Engage partners personally invest in every company that we present to our Investor Network.

2022

Founded

15

Investments completed

$13M+

Total capital invested

4-6

Investments per year

Investment criteria

What we look for in a company

Every company we bring to the Network is assessed against the same criteria. These are the questions we work through before we invest our own money.

Team

  • Top-quality team with experience in the relevant field
  • Clinical, scientific, and business advisors who add credibility
  • Scrappiness, and a track record of doing more with less

Market need

  • An unmet clinical need, not a solution looking for a problem
  • Need validated by real-world clinicians
  • A large addressable market with realistic penetration assumptions

Product

  • R&D, design, and testing milestones achieved for a minimum viable product
  • User feedback or preclinical data where possible
  • Visibility to future products and product extensions

Intellectual property

  • Clear, defensible patents granted or filed, with more in process
  • Freedom to operate in the relevant jurisdictions
  • Where IP is not patentable, real barriers to entry and a plan to protect the core technology

Regulatory

  • We typically invest before a device is cleared or approved
  • A clear understanding of the pathway in the US and abroad
  • Realistic timelines

Commercialization

  • A defined go-to-market strategy, with initial commercial partnerships identified
  • A compelling plan for how the product gets paid for, through reimbursement or value analysis

Competition

  • A real understanding of direct and indirect competitors
  • Early market leadership with clear differentiation

Exit strategy

  • An identified plan for exiting the business
  • Multiple potential strategic acquirers
  • Already on the radar of those acquirers

Our approach

How an Engage investment comes together

We offer a select group of investors, the Engage Investor Network, the opportunity to co-invest in companies that have passed our rigorous due diligence process. Supported by our in-depth research and due diligence information, our investors have the full discretion to pick and choose which companies to support.

Source and curate

We leverage our industry knowledge and connections to source proprietary deal flow across the US.

Due diligence

We rigorously assess the company's clinical, technical, regulatory, IP, commercialization, and financial strengths and risk factors, and write our comprehensive Due Diligence Research Report.

Announce and opt in

We announce the deal to the Investor Network. If you are interested in learning more, you can opt in to receive our Due Diligence Research Report and join our investor presentations, with no obligation to invest.

Investor presentations

You hear directly from the company's CEO, and then join a due diligence review session led by Engage partners.

SPV and funding

Engage creates a separate Special Purpose Vehicle for each investment, and you fund your position into it.

The Engage Investor Network

Co-invest deal by deal, with full discretion over every one

Who is eligible

To participate in Engage co-investment opportunities, you must be an accredited investor. Individuals, family offices, trusts, and institutional investors are eligible.

What it takes to join

There are no sign-up fees, subscription fees, or participation commitments. You join by signing our Services Agreement.

Joining the network

If you are interested in joining the Engage Investor Network, let’s chat!

Contact us about joining

Portfolio

The companies we have backed

Every company below was identified by an Engage partner, went through our due diligence process, and was funded by Engage partners alongside the Engage Investor Network.

Melodi Health, Inc.
Agitated Solutions, Inc.
Vocxi Health, Inc.
Dosentrx Ltd.
Pleural Dynamics, Inc.
Laplace Interventional, Inc.
Diatiro, Inc.
Myrava, Inc.

Our team

Veteran early-stage investors, entrepreneurs, and operators

Morgan Evans

Morgan Evans

Managing Director

Morgan is a medtech founder and executive with a background in general management, M&A, business development, R&D, clinical, and sales. Morgan is Co-Founder and CEO of Agitated Solutions, a medical device company, Co-Founder of Moonshot Medical, a medical device incubator, and Founder of Avio Medtech Consulting, a medtech services firm focused on development, quality, regulatory, and strategy consulting. She started her career at Autonomic Technologies Inc, a venture-backed neuromodulation startup, before joining Medtronic in Corporate Development. Morgan was recognized in 2026 by Inc. as a Female Founders 500 honoree and by Minneapolis/St. Paul Business Journal as a 40 Under 40 winner. She was named a TCB 100 honoree in 2023 by Twin Cities Business.

Stephen H. Sigmond

Stephen H. Sigmond

Managing Director

Steve is a technology and finance executive with more than 30 years of experience investing in, advising, and running early-stage companies. His most recent exit was as Founder, CFO, and VP Marketing at Carrot Health, a healthcare data and analytics SaaS company that was acquired in 2021. Previously, Steve was a Venture Partner at BlueStream Ventures, a $280 million venture capital fund, and Managing Director, Equity Research at RBC Capital Markets. Steve was recognized in 2021 by Twin Cities Business as a Notable Leader in Finance, by Institutional Investor as a Home Run Hitter and Best of the Boutiques research analyst, and twice by The Wall Street Journal as a Best on the Street winner.

Contact

Tell us what you are building, or what you are looking for

Engage Venture Partners is based in Minneapolis, Minnesota, in the heart of Medical Alley.

For founders

Raising a seed or start-up round

Send us the company, the stage, and what the round is meant to accomplish. Our partners read every inbound company themselves.

info@engagevp.com

For investors

Joining the Investor Network

Accredited individuals, family offices, trusts, and institutional investors are eligible. There is no fee and no commitment to join.

info@engagevp.com

Get in touch

We respond to every message

Thanks. Your message is on its way and we will get back to you.